Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Lane

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
American Journal of Translational Research|December 8, 2009
Microarray gene expression profiling using core biopsies of renal neoplasiaCraig G Rogers, Jonathon A Ditlev, Min-Han Tan, et al.
British Journal of Cancer|April 13, 2021
A miRNA signature predicts benefit from addition of hypoxia-modifying therapy to radiation treatment in invasive bladder cancerMairah T Khan, Joely J Irlam-Jones, Ronnie Rodrigues Pereira, et al.
European Urology Oncology|April 5, 2021
Incidental Prostate Cancer (cT1a-cT1b) Is a Relevant Clinical and Research Entity and Should Be Fully Discussed in the International Prostate Cancer GuidelinesUmberto Capitanio, Riccardo Autorino, Marco Bandini, et al.
Urology|August 11, 2020
Overtreatment and Underutilization of Watchful Waiting in Men With Limited Life Expectancy: An Analysis of the Michigan Urological Surgery Improvement Collaborative RegistryUdit Singhal, Jeffrey J Tosoian, Ji Qi, et al.
Cancer Research|July 19, 2012
Expression of the PTTG1 oncogene is associated with aggressive clear cell renal cell carcinomaBill Wondergem, Zhongfa Zhang, Dachuan Huang, et al.
Plos One|July 30, 2011
siRNA knockdown of ribosomal protein gene RPL19 abrogates the aggressive phenotype of human prostate cancerAlix Bee, Daniel Brewer, Carol Beesley, et al.
European Urology Oncology|March 21, 2026
Monogenic and Polygenic Risk for Kidney Cancer in Two Large BiobanksJun Wei, Ashley J Mulford, Zhuqing Shi, et al.
European Urology|July 28, 2023
Does Urologist-level Utilization of Active Surveillance for Low-risk Prostate Cancer Correspond with Utilization of Active Surveillance for Small Renal Masses?Michael Wang, Sophie Wittenberg, Michael L Cher, et al.
Scientific Reports|August 6, 2017
Recognizing the Continuous Nature of Expression Heterogeneity and Clinical Outcomes in Clear Cell Renal Cell CarcinomaXiaona Wei, Yukti Choudhury, Weng Khong Lim, et al.
Molecular Medicine Reports|June 22, 2022
Comparison of multiple gene expression platforms for measuring a bladder cancer hypoxia signatureTim A D Smith, Brian Lane, Elisabet More, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
American Journal of Translational Research|December 8, 2009
Microarray gene expression profiling using core biopsies of renal neoplasiaCraig G Rogers, Jonathon A Ditlev, Min-Han Tan, et al.
British Journal of Cancer|April 13, 2021
A miRNA signature predicts benefit from addition of hypoxia-modifying therapy to radiation treatment in invasive bladder cancerMairah T Khan, Joely J Irlam-Jones, Ronnie Rodrigues Pereira, et al.
European Urology Oncology|April 5, 2021
Incidental Prostate Cancer (cT1a-cT1b) Is a Relevant Clinical and Research Entity and Should Be Fully Discussed in the International Prostate Cancer GuidelinesUmberto Capitanio, Riccardo Autorino, Marco Bandini, et al.
Urology|August 11, 2020
Overtreatment and Underutilization of Watchful Waiting in Men With Limited Life Expectancy: An Analysis of the Michigan Urological Surgery Improvement Collaborative RegistryUdit Singhal, Jeffrey J Tosoian, Ji Qi, et al.
Cancer Research|July 19, 2012
Expression of the PTTG1 oncogene is associated with aggressive clear cell renal cell carcinomaBill Wondergem, Zhongfa Zhang, Dachuan Huang, et al.
Plos One|July 30, 2011
siRNA knockdown of ribosomal protein gene RPL19 abrogates the aggressive phenotype of human prostate cancerAlix Bee, Daniel Brewer, Carol Beesley, et al.
European Urology Oncology|March 21, 2026
Monogenic and Polygenic Risk for Kidney Cancer in Two Large BiobanksJun Wei, Ashley J Mulford, Zhuqing Shi, et al.
European Urology|July 28, 2023
Does Urologist-level Utilization of Active Surveillance for Low-risk Prostate Cancer Correspond with Utilization of Active Surveillance for Small Renal Masses?Michael Wang, Sophie Wittenberg, Michael L Cher, et al.
Scientific Reports|August 6, 2017
Recognizing the Continuous Nature of Expression Heterogeneity and Clinical Outcomes in Clear Cell Renal Cell CarcinomaXiaona Wei, Yukti Choudhury, Weng Khong Lim, et al.
Molecular Medicine Reports|June 22, 2022
Comparison of multiple gene expression platforms for measuring a bladder cancer hypoxia signatureTim A D Smith, Brian Lane, Elisabet More, et al.
Pageof 7